Literature DB >> 15260934

Acupuncture for chronic prostatitis/chronic pelvic pain syndrome.

Richard C T Chen1, J Curtis Nickel.   

Abstract

Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is prevalent in urological practice and has a significant impact on quality of life. Standard therapies often fail to achieve sustainable amelioration of symptoms. This article attempts to show that neuromodulatory treatment in the form of electroacupuncture can be a minimally invasive and effective treatment for CP/CPPS that is refractory to standard therapies. This neuromodulatory therapy lends support to the hypothesis that the end stage of CP/CPPS may be a neuropathic pain syndrome.

Entities:  

Mesh:

Year:  2004        PMID: 15260934     DOI: 10.1007/s11934-004-0057-z

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  25 in total

Review 1.  The three As of chronic prostatitis therapy: antibiotics, alpha-blockers and anti-inflammatories. What is the evidence?

Authors:  J Curtis Nickel
Journal:  BJU Int       Date:  2004-12       Impact factor: 5.588

Review 2.  Anatomy of the central neural pathways controlling the lower urinary tract.

Authors:  W C de Groat
Journal:  Eur Urol       Date:  1998       Impact factor: 20.096

3.  [Effect of acupuncture on the pons micturition centre and the related function of the urinary bladder].

Authors:  Z X Zhang; H Zhang; D Z Wu
Journal:  Zhen Ci Yan Jiu       Date:  1987

4.  Suppression of noxious responses in single neurons of cat spinal cord by electroacupuncture and its reversal by the opiate antagonist naloxone.

Authors:  B Pomeranz; R Cheng
Journal:  Exp Neurol       Date:  1979-05       Impact factor: 5.330

5.  The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network.

Authors:  M S Litwin; M McNaughton-Collins; F J Fowler; J C Nickel; E A Calhoun; M A Pontari; R B Alexander; J T Farrar; M P O'Leary
Journal:  J Urol       Date:  1999-08       Impact factor: 7.450

6.  A combined treatment with D-amino acids and electroacupuncture produces a greater analgesia than either treatment alone; naloxone reverses these effects.

Authors:  Richard S S Cheng; Bruce Pomeranz
Journal:  Pain       Date:  1980-04       Impact factor: 6.961

7.  [Clinical studies on chronic prostatitis and prostatitis-like syndrome (7). Electric acupuncture therapy for intractable cases of chronic prostatitis-like syndrome].

Authors:  T Ikeuchi; H Iguchi
Journal:  Hinyokika Kiyo       Date:  1994-07

8.  Alterations of immunoreactive substance P and enkephalins in rat spinal cord after electroacupuncture.

Authors:  L L Vacca-Galloway; N E Naftchi; K Arakawa; X M Guan; M K Ai
Journal:  Peptides       Date:  1985       Impact factor: 3.750

9.  Cytokine polymorphisms in men with chronic prostatitis/chronic pelvic pain syndrome: association with diagnosis and treatment response.

Authors:  Daniel A Shoskes; Qussay Albakri; Kim Thomas; Daniel Cook
Journal:  J Urol       Date:  2002-07       Impact factor: 7.450

10.  Serotonergic modulation of spinal ascending activity and sacral reflex activity evoked by pelvic nerve stimulation in cats.

Authors:  M J Espey; H J Du; J W Downie
Journal:  Brain Res       Date:  1998-07-06       Impact factor: 3.252

View more
  3 in total

1.  [Chronic pelvic pain syndrome: neurostimulation, neuromodulation and acupuncture].

Authors:  M Walter; U Sammer; T M Kessler
Journal:  Urologe A       Date:  2012-12       Impact factor: 0.639

2.  Using meta-regression approach to explore the dose-response association between acupuncture sessions and acupuncture effects on chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Zongshi Qin; Jiani Wu; Chang Xu; Zhishun Liu
Journal:  Ann Transl Med       Date:  2019-03

Review 3.  Therapeutic options for chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Jeannette M Potts
Journal:  Curr Urol Rep       Date:  2005-07       Impact factor: 2.862

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.